Daily Market Movers 02-19-09

FEATURED COMPANY

SPONGETECH DELIVERY SYSTEMS (OTCBB: SPNG)

Detailed Quote: http://www.otcpicks.com/quotes/SPNG.php

Company Profile: http://www.otcpicks.com/spongetech/spongetech.htm

SpongeTech Delivery Systems is a development stage company which designs, produces, markets and distributes cleaning products for vehicular use utilizing patented technology relating to sponges containing hydrophilic (liquid absorbing) foam polyurethane matrices. The Company's sponges are specially configured with an outer contact layer and an inner matrix, which is loaded with specially formulated soaps and wax that are released when the sponge is applied to a surface with minimal pressure. The Company's products are currently designed specifically for vehicular cleaning use. However, the Company is exploring the possibility of using its patented technology for the development of sponges for other uses, including for use with anti-bacterial, bath and kitchen soaps for household uses, as well as for use as a children's bath foam sponge.

SPNG News:

February 19 - SpongeTech® Delivery Systems, Inc. Receives Initial Order From CVS Caremark

SpongeTech® CVS Initial Order for in Excess of a $500,000.00

SpongeTech Delivery Systems, Inc. (OTCBB: SPNG), America's Cleaning Company™, announced an initial order from CVS Caremark (NYSE: CVS) is in excess of $500,000. The order consists of the Company's auto and pet line products.

The SpongeTech products will be available on shelves in over 6,000 CVS Stores nationwide mid-March. This order is indicative of the Company's continued efforts to introduce our products into quality national retail chains; we anticipate great success with CVS and will be announcing additional retailers in the near future.

SpongeTech COO, Steven Moskowitz, stated, "I continue to be pleased with the roll out of our products nationally as well as the sell-through we are seeing for our products, which I directly attribute to the quality of product as well our ongoing marketing campaign. This order is early in the season, with great opportunity for re-orders as we get into the spring summer 'prime car wash season'."

SpongeTech® Delivery Systems, Inc. CEO Interviewed Live on Steve Crowley's American Scene Radio Show

SpongeTech's CEO Interview Airs Friday on American Scene Radio Show

SpongeTech® Delivery Systems, Inc. (OTCBB: SPNG), America's Cleaning Company™, announces that its CEO and President, Michael Metter, will be interviewed Thursday, Feb. 19, on Steve Crowley's “American Scene Radio Show” at 9:24 a.m. EST. The interview can be heard live on BusinessTalkRadioNetwork® affiliate radio stations streamed on its website, www.businesstalkradio.net. You can find local radio stations by accessing the website, as well. Mr. Metter will be scheduled for future interviews on American Scene, where he will keep listeners updated on SpongeTech's products and developments.

FEATURED COMPANY

DOCUMENT CAPTURE TECHNOLOGIES (OTCBB: DCMT)

Detailed Quote: http://www.otcpicks.com/quotes/DCMT.php

Company Profile: http://www.otcpicks.com/document-capture-technologies/document-capture-technologies.htm

Document Capture Technologies (DCT) is a worldwide leader in the design, development, manufacturing, and sale of USB powered mobile page-fed document capture solutions. Its vertical integration and innovative proprietary system development kits allow for a broad range of applications, faster time-to-market and ease of integration for its customers. DCT has more than 45 key accounts, predominantly in North America and a growing intellectual property (IP) portfolio that currently numbers more than 25 granted domestic and international patents as well as 3 pending. DCT maintains an aggressive IP strategy to defend its technology and market leadership position. DCT provides more than 30 different products across five distinct categories, which are distributed globally through private label solutions to leading Tier 1 OEMs, VAR’s and other system integrators, including Qualcomm and Brother. DCT has steadily grown its business (37% three-year organic CAGR) in the health care, security, financial and compliance vertical markets. The company and its licensees currently enjoy greater than a 70% share of the USB-powered mobile scanner market.

DCMT News:

February 17 - Document Capture Technologies Notes Release of SmallcapInsights.com Op-Ed Discussing Strategic 'Bottom Fishing'

Document Capture Technologies, Inc. (OTCBB: DCMT), an IP-driven leader in the design, development and sale of next-generation mobile scanning technologies, announced the release of a SmallcapInsights.com article entitled, “Go Ahead, Pick the Bottom, I Dare You.”

Written by the Editor of SmallcapInsights.com, a newly launched online investor portal, the Tuesday, February 17th 2009 article discusses some corporate metrics for investors to look for as they begin to return to the market. The article muses that investors should seek out stocks with cash and no debt and then look at the business.

The Editor noted: “I read online that there is nearly $9 trillion in cash idling on the market sidelines. Apparently that’s about 75 percent of the total market value of US companies. It hasn’t been that high since 1990. While the cash on the sidelines argument is always the refuge of the perma-bull, the fact is that following eight previous peaks, the S&P shot up an average of 24 percent in six months. That would sure help the college fund.”

A link to this article is available at www.smallcapinsights.com.

FEATURED COMPANY

ADVANCED CELL TECHNOLOGY INCORPORATED (OTC: ACTC)

Detailed Quote: http://www.otcpicks.com/quotes/ACTC.php

Company Profile: http://www.otcpicks.com/advanced-cell-technology/advanced-cell-technology.htm

Advanced Cell Technology, Inc., a biotechnology company, engages in the development and commercialization of human embryonic and adult stem cell technology in the field of regenerative medicine. It primarily focuses on cellular reprogramming, reduced complexity program, and stem cell differentiation research programs. The company also develops adult stem cell-based products that are specifically targeted at therapies for heart and other cardiovascular diseases. It also plans to develop and commercialize products for use in the treatment of an array of chronic degenerative diseases and in regenerative repair of acute disease, such as trauma, infarction, and burns. The company has research and license agreements with University of Massachusetts, Wake Forest University, WiCell Research Institute, Inc., Kirin Beer Kabushiki Kaisha, and Start Licensing. Advanced Cell Technology, Inc. is headquartered in Worcester, Massachusetts.

ACTC News:

February 3 - Cloned Human Embryos Successfully Reprogrammed Using Human Eggs

Study by Advanced Cell Technology and collaborators questions ability of human-animal hybrids to generate stem cells

Advanced Cell Technology, Inc. (OTC: ACTC) and its collaborators reported that human oocytes (or ‘eggs’) have the capacity to extensively reprogram adult human cells. The research, which appears online ahead of print in the journal Cloning and Stem Cells (Editor-in-Chief: Sir Ian Wilmut; published by Mary Ann Liebert, Inc.) demonstrates that although human-to-human clones (human clones) and human-to-animal clones (hybrids) appear similar, the pattern of reprogramming of the donor human cell is dramatically different. In contrast to the human-animal hybrids, the gene expression pattern of the human clones was highly similar to normal human embryos. The paper is available free online at www.liebertpub.com/clo.

Since the cloning of Dolly the Sheep over a decade ago, somatic cell nuclear transfer (SCNT) has been considered a promising way to generate personalized stem cells to repair the body without fear of tissue rejection. Due to the serious shortage of human donor eggs, cows, rabbits, and other animals have long been considered an attractive surrogate source of eggs. Although previous reports have documented the formation of cloned embryos using both human and animal eggs, to-date, there has been no data indicating whether – and to what extent - the donor DNA was reprogrammed.

This new study looked at the reprogramming of human cells using eggs obtained from human and animal sources, and shows for the first time that the donor DNA in the cloned human embryos is extensively reprogrammed through extensive up-regulation (‘turning on’ of genes) with similar expression patterns to normal human embryos. Nearly all of the key differentially-expressed genes were activated in the human clones. In distinct contrast, the majority of these genes were down-regulated or silenced in the human-animal hybrids.

“We examined the factors recently used to reprogram skin cells (to induce pluripotent stem cells),” said Robert Lanza, MD, Chief Scientific Officer at ACT, and senior author of the study. “At the center of cellular reprogramming lies the activation of the transcription factors Oct4, Sox2, and nanog. These core factors were activated in both the normal and cloned human embryos. In striking contrast, the human-animal hybrids showed no difference or a down-regulation of these critical pluripotency genes -effectively silencing them—thus making the generation of stem cells impossible. Without appropriate reprogramming, these data call into question the potential use of animal egg sources to generate patient-specific stem cells. It also renders the moral controversy surrounding the use of human-animal hybrids moot.”

Previous studies have confirmed the ability of animal eggs to support interspecies cell division to the embryo stage, and in a few closely-related bovid species, successful development to term. However, there are clear differences in compatibility. Distantly-related animal combinations generally arrest at the cleavage-stage, although there have been reports of blastocyst formation. Our group and others have successfully used eggs to clone closely-related species (for instance, we cloned two endangered species – the guar and banteng - using cow eggs). Rabbit eggs have also been used to generate embryos using cells from cats and panda, among others. However, it remains unknown whether the DNA in the later combinations was fully reprogrammed. Importantly, except for a study carried out in China (which to-date has proven irreproducible despite attempts by numerous groups in the last half-decade), there is no evidence that patient-specific stem cells can be generated using animal eggs. This is consistent with studies that indicate that eggs support nuclear remodeling, but not reprogramming of discordant animal combinations. Studies using cow and rabbit eggs clearly suggest that DNA methylation/demethylation of the donor DNA occurs in a species-specific way, and that the eggs might lack the ability to demethylate repetitive sequences from other species. While cleavage division relies on maternal factors in the egg, further development requires activation of the embryonic genome to ensure correct progression of the cell cycle. These new results suggest that while bovine and rabbit eggs are capable of supporting limited cell division, specific reprogramming towards the normal human embryonic state does not occur.

Wide scale application of stem cell technology will require a solution to the problem of rejection. This report suggests that adult cells can be successfully reprogrammed using human eggs, and that scientists may soon have two ways (SCNT and induced pluripotent stem cell technology) to reprogram adult cells into stem cells. However, until this is achieved, clinical trials are likely to be limited to immune-privileged sites in the body, such as the use of cells in the central nervous system, or the transplantation of ACT’s retinal cells into the eye to prevent blindness.

“Producing millions of patient-specific stem cell lines is commercially unviable,” stated William M. Caldwell, CEO and Chairman of ACTC. “However, we are optimistic that we will soon have at least two different methods to create stem cells banks to match patients. We estimate that a bank of 100 different lines could furnish a complete tissue (HLA haplotype) match for half of the US population. This will allow us to expand the range of possible clinical therapies to include diseases such as diabetes and heart disease.”

The paper’s other authors are Young Chung (first author), Vladislav Sandler, Sandy Becker, Irina Klimanskaya, Shi-Jiang Lu & Marc Maserati of ACT; Colin Bishop, Stephen Walker & Anthony Atala at Wake Forest University School of Medicine; Nathan Treff, Jing Su & Richard Scott at Reproductive Medicine Associates of New Jersey; Randall Dunn at Fertility Specialists of Houston; Wan-Song Wun, Rebecca Hall & Ralph Dittman at Stem Cell Source; and Young-Ho Choi at Texas A&M University.

FEATURED COMPANY

WIND ENERGY AMERICA INCORPORATED (OTCBB: WNEA)
"Up 20.00% in morning trading"

Detailed Quote: http://www.otcpicks.com/quotes/WNEA.php

Company Profile:
www.otcpicks.com/wind-energy-america/wind-energy-america-2.htm

Wind Energy America Inc. develops and operates wind energy projects in the Great Plains and the Midwest, regions known for their high quality wind energy resources. The Company owns interests in three wind farms: Shaokatan Hills LLC, Lakota Ridge LLC and CHI Energy. At present, WNEA owns a developer's stake and a minimal interest producing negligible cash flow in these wind farms. Over the next two years the developer’s stake will begin producing significant cash flow from these projects. The three wind farms together contain 79 modern wind turbines and have a total rated capacity of 53.5 megawatts (MW). They are collectively generating approximately 160 million kilowatt hours (kWh) of electricity annually. In addition to these properties, the Company owns a 3 percent equity interest in Averill Wind LLC, a 10 MW wind farm being developed near Fargo, N.D., another region favorable for wind power energy.

WNEA News:

November 19 - Wind Energy America Inc. Obtains Financing to Complete Minnesota Wind Farm

Wind Energy America Inc. (OTCBB: WNEA) announced that it has started ordering parts and commencing construction and interconnect operations to complete its wind farm project in Minnesota which contains two of the Gamesa wind turbines acquired in the Boreal Energy asset purchase. When commissioning of these two turbines is completed, WNEA will receive its first material revenues from generating utility-scale electricity from wind power. This Buffalo Ridge wind farm and its revenue production will be 100% owned by WNEA.

Financing for this wind farm project was obtained from a California holding company through a sale/leaseback of our Midwest Energy Center facility in Lincoln County MN. WNEA received net proceeds of approximately $l,400,000 from this sale/leaseback transaction. We also have the option after 2 years to repurchase the facility at a price which represents a small percentage increase over the initial sale/leaseback price.

Robert Knutson, managing director of WNEA and the person responsible for obtaining and closing this significant funding, stated: “Given the current difficulties of raising development capital due to the recent collapse of worldwide equity markets, we are pleased that WNEA has been able to obtain critical funding at this time. These proceeds have enabled us to satisfy substantial overdue bank debt secured by the project, pay for interconnect and other costs owed to the utility which will purchase electricity generated by the project, acquire the necessary transformer equipment and other wind turbine parts and materials, and retain an experienced wind power contractor to complete the project for us.”

FEATURED COMPANY

QUOTEMEDIA INCORPORATED (OTCBB: QMCI)

Detailed Quote: http://www.otcpicks.com/quotes/QMCI.php

Company Profile: http://www.otcpicks.com/quotemedia/quotemedia.htm

QuoteMedia, Inc. is a leading software developer and provider of real-time streaming financial market information, decision-support, news and research solutions to brokerage, financial services companies, business and media corporations. Among its many leading-edge products lines, the Company offers data feeds, news, dynamic market content solutions, interactive stock research tools, financial applications and real-time wireless applications. QuoteMedia provides data and services for companies such as the NASDAQ, the OTCBB, Dow Jones & Company, Forbes.com, Scotia Capital, Business Wire, Southwest Securities, Regal Securities, FBR Direct, Broadridge Financial Solutions, Inc., AIM Trimark, Zacks Investment Research, ChoiceTrade, QTrade, Schaeffer's Investment Research, Automated Financial Systems, WallStreet*E, and others. For more information, visit www.quotemedia.com.

QMCI News:

February 3 - QuoteMedia Launches Quotestream Wireless for the iPhone

QuoteMedia, Inc. (OTCBB: QMCI) announced the launch of a custom version of Quotestream™ Wireless for use on the iPhone™, Apple Inc.’s Internet-connected multimedia smartphone.

Quotestream Wireless is a comprehensive, feature-rich wireless market data application for PDAs, cell phones and other handheld devices that connects users to critical financial information while on the go. It features streaming real-time market data, multiple streaming portfolios, detailed stock quotes, intraday and historical charts, corporate news and events, audio and vibration alerts, level II market depth, time and sales, market indices, tick trend indicators, online trading and more.

“The market for applications that function on the iPhone is enormous, and it's growing quickly,” said Dave Shworan, CEO of QuoteMedia, Ltd. “The iPhone is truly a breakthrough product, incorporating leading-edge multimedia, communication and Internet technologies within a mobile phone based on Apple's revolutionary multi-touch interface. This custom version of Quotestream Wireless is specifically designed to take advantage of the unique features of the iPhone, to offer users the ability to keep on top of the financial markets from anywhere, with a combination of unmatched depth of information and ease of use.”

Quotestream Wireless is also a companion product to QuoteMedia’s line of streaming real-time desktop applications, including Quotestream II, which is geared towards providing a professional level experience to non-professional users, and Quotestream Professional, which is designed specifically for use by financial services professionals, offering unparalleled functionality at extremely aggressive pricing. Any changes made to portfolios in either the desktop or wireless application are automatically reflected in the other.

“Quotestream Wireless is truly a differentiator for our company, as it allows our users to stay on top of what is happening in the markets, no matter where they are. This is particularly important among market professionals and serious non-professional investors, who require the ability to retrieve dynamic stock market information and the capability to execute a trade whether at the office or on the road,” said Shworan. “Brokers and investors need access to market information at all times, and in all places, but it’s impossible to spend all of your time in front of your desktop computer. With Quotestream Wireless, we let those individuals take the market with them, wherever they go, and the industry is responding very positively.”

STOCKS TO WATCH

HUMAN BIOSYSTEMS INCORPORATED (OTCBB: HBSC)
"Up 92.31% in morning trading"

Detailed Quote: http://www.otcpicks.com/quotes/HBSC.php

Human Biosystems, a development stage company, develops preservation platforms for organs, blood platelets, and other biomaterials in the United States and Russia. It is developing proprietary above zero (HBS-AZ) and below zero (HBS-BZ) organ and issue preservation systems and methods for preserving platelets, red blood cells, heart valves, tissues, and organs. The company also involves in the development of its Platelet Preservation System, a proprietary technology that extends the shelf life of blood platelets and other biological material. It customers include blood banks, hospitals, clinics, and other organizations. The company was founded in 1998. It was formerly known as HyperBaric Systems and changed its name to Human BioSystems in 2002. Human BioSystems is headquartered in Palo Alto, California.

HBSC News:

February 18 - Human BioSystems Signs Non-Binding Letter of Intent for a Reverse Merger With San West, Inc.

Human BioSystems Inc. (OTCBB: HBSC), a Silicon Valley based bio-tech company specializing in the development of unique organ, tissue and cellular preservation platforms, has signed a non-binding letter of intent which contemplates a proposed reverse merger with San West, Inc.

Under the terms of the non-binding LOI, San West, Inc. would acquire 85% of the outstanding common stock of Human BioSystems, pursuant to the contemplated merger exchange agreement. Following the closing of the anticipated merger, San West would emerge as the surviving company with a name and symbol change to follow.

In addition, HBS shareholders would retain approximately 15% of the new company's outstanding shares upon completion of the anticipated merger. The merger is subject to a number of conditions, including the signing of a definitive merger agreement by March 1, 2009, the completion of financing arrangements between the two parties, and positive final due diligence results reported on behalf of both parties.

Commenting on the potential merger, San West CEO Frank Drechsler stated: "After significantly growing our business over the past few years, I strongly believe that the next logical step in our corporate development is having our stock quoted for sale in a public market. The greater access to capital and overall visibility afforded by operating as a publicly traded organization should play an instrumental role in our ability to expand both through acquisition and the organic growth of our existing off-road business.

Mr. Drechsler concluded, "My due diligence to date reveals strong evidence that a potential reverse merger with Human BioSystems represents a solid opportunity to take the San West business model to the next level. I look forward to updating the public on our progress with regard to pursuing this agreement in the very near future."

HBS CEO Harry Masuda added, "Our efforts to raise the necessary capital to complete our planned platelet studies using human subjects has been very difficult at best. A potential business partner for our organ preservation technology fell through, leaving us with few options but to seek a merger partner or to attempt to sell the company." Mr. Masuda concluded: "I believe that a merger with San West USA Inc. is the best option for our company given the current financial situation of HBS and the general negative economic climate for raising capital for a development stage company such as ours. If a definitive merger agreement is signed, the ongoing products will be that of San West and the current business of Human BioSystems will be suspended and other options will be considered for its business."

ABOUT SAN WEST, INC.

San West Inc. finds its niche in the off-road arena improving designs of buggy manufactures and, selling these products and services as well as repairing of these off-road buggies and additionally providing after market performance products and accessories for buggies. Our products are sold both at our Buggy World is the exclusive authorized sales; service and parts distributor for the San Diego County with a factory trained staff that can answer all product and service questions. Buggy World currently has two retail locations in San Diego County California as well as a growing Internet presence.

POWER MEDICAL INTERVENTIONS INCORPORATED (NASDAQ: PMII)
"Up 99.98% in morning trading"

Detailed Quote: http://www.otcpicks.com/quotes/PMII.php

Power Medical Interventions®, Inc. is the world's only provider of computer-assisted, power-actuated surgical stapling products. PMI's Intelligent Surgical Instruments™ enable less invasive surgical techniques to benefit surgeons, patients, hospitals and healthcare networks. PMI manufactures durable recyclable technology to reduce medical waste and help keep the planet clean. The company was founded in 1999, and is headquartered in Langhorne, PA with additional offices in Germany, France, and Japan.

PMII News:

February 17 - Power Medical Interventions, Inc. Receives FDA 510(k) Marketing Clearance for i60RL Intelligent Surgical Instruments™

First-of-Its-Kind Instrument Provides Surgeons With Greater Access to Key Anatomical Sites

Power Medical Interventions® Inc. (Nasdaq: PMII), a leader in developing and commercializing Intelligent Surgical Instruments™, announced that the U.S. Food and Drug Administration has cleared its 510(k) application for marketing its patented i60RL Intelligent Surgical Instrument. The i60RL Intelligent Surgical Instrument is the world's first reverse pivot linear cutter, designed to improve medical outcomes by providing surgeons with greater access to important anatomical sites that are currently difficult to reach. The i60RL will be available for applications throughout the digestive tract. The Company intends to launch the product in April 2009.

In addition, PMI received approval from an Institutional Review Board to conduct a study on the effectiveness of the i60RL in the treatment of gastroesophageal reflux disease (GERD). GERD is a digestive disorder that affects the lower esophageal sphincter, the muscle connecting the esophagus with the stomach. It is estimated that millions of Americans are affected by this disease. The study will be conducted at the University of Chicago and will be lead by John Alverdy, M.D., Professor of Surgery and Head of the Minimally Invasive Lab at the University of Chicago.

Dr. Alverdy commented, “Gastroesophageal reflux disease or GERD affects millions of Americans annually. If the study is successful, it will support our belief that the i60RL will provide an effective minimally invasive treatment alternative for patients suffering from GERD.”

Michael Whitman, President and Chief Executive Officer, commented, “The i60RL is the world's first reverse pivot linear cutter, providing surgeons with the ability to access difficult to reach anatomical sites. We believe that Dr. Alverdy and the four clinical sites to be selected to conduct this study will provide us with the data to help us to prove the effectiveness of this device and illustrate the numerous benefits it will bring to both surgeons and patients. It is anticipated that the procedure, utilizing the i60RL, may take as little as thirty minutes to complete and will serve as an alternative to widely used prescription drugs and invasive surgeries. The i60RL is a unique and proprietary addition to PMI's growing line of Intelligent Surgical Instruments and further validates the possibility for PMI's technology to facilitate the creation of new clinical indications in minimally invasive surgery.”

PMI's Intelligent Surgical Instruments are computer-assisted, power-actuated endomechanical instruments that surgeons use for cutting, stapling and tissue manipulation in a variety of procedures in open surgery and minimally invasive surgery. The Company believes that compared to conventional endomechanical devices, its Intelligent Surgical Instruments offer greater precision and consistency, superior compressive force, improved access to anatomical sites and enhanced ease of use.

MESA AIR GROUP INCORPORATED (NASD: MESA)
"Up 6.81% in morning trading"

Detailed Quote: http://www.otcpicks.com/quotes/MESA.php

Mesa Air Group, Inc., through its subsidiaries, provides scheduled passenger and airfreight services. It carries passengers, as well as freight and express packages on its passenger flights. The company also has interlined small cargo freight agreements with various other carriers. In addition, Mesa Air Group contracts with the U.S. Postal Service for carriage of mail to the cities it serves. Further, it occasionally operates charter flights. As of September 30, 2007, the company operated a fleet of 182 aircraft with approximately 1,100 daily departures to 184 cities in the United States, the District of Columbia, Canada, the Bahamas, and Mexico. Mesa Air Group was founded in 1980 and is headquartered in Phoenix, Arizona.

MESA News:

February 18 - Mesa Air Group Reports First Quarter 2009 Results and go! Achieves First Profitable Quarter

Mesa Air Group, Inc. (Nasdaq: MESA) (the "Company") announced first quarter net income from continuing operations of $15.5 million on operating revenues of $265.1 million. Total operating revenues for the first quarter of 2009 decreased $61.5 million, or 18.8% primarily resulting from a year-over-year decrease in capacity and lower fuel revenue. The net income of $15.5 million, or $0.46 per share on a diluted basis, compares to net loss from continuing operations of $2.8 million, or $0.10 per diluted share for the same period of fiscal 2008. Pro forma net income for the quarter was $10.0 million or $0.31 per diluted share. Pro forma net income for the quarter includes adjustments for the following items on an after tax basis: $5.0 million gain on extinguishment of debt, $0.8 million income from equity method investments, $0.5 million of go! legal, $0.4 million in startup costs associated with our Chinese joint venture, $0.2 million of lease return costs, and $0.1 million loss on disposal.

Total Available Seat Miles ("ASM's") for the first quarter of fiscal 2009 decreased 18.4% from the first quarter of 2008. The decrease was primarily due to a reduction in the number of aircraft flown from 183 as of December 31, 2007 to 151 as of December 31, 2008. At December 31, 2008 Mesa's operating fleet was comprised of 77 50-seat regional jets, 38 86-seat regional jets, 20 66-seat regional jets and 16 37-seat turboprops. As of December 31, 2008, the Company operated 49 regional jets and six turboprops on a codeshare basis with US Airways, 46 regional jets and ten turboprops for United, 34 regional jets for Delta, and had one operational spare. The Company also flew five regional jets in Hawaii, operating as go!

As of December 31, 2008, the Company's cash, marketable securities and restricted cash were approximately $64.0 million. In the second quarter of fiscal 2009 and similar to prior years, the Company will be making significant aircraft lease payments that will impact our cash position.

Events during the first quarter included:

* The go! operation generated approximately $0.5 million of net income on $11.6 million of revenue for the first fiscal quarter of 2009. Available seat miles increased in the first quarter 15.4% in comparison to the same period in the prior fiscal year. Fuel prices were reduced significantly in the quarter and go! experienced increases in passenger revenue, and load factor. Departures increased 11.4% and passengers carried increased 11.3% over the first quarter of 2008.

* On November 28, 2008 Mesa announced entering into a settlement with the former controlling shareholder of Aloha Airlines concerning the Aloha Airlines lawsuit over Mesa's Hawaiian inter-island flight services operated under the go! brand name. Under the terms of the settlement and without admitting any wrongdoing, Mesa agreed to make a $2.0 million cash payment, issue shares of common stock equal to 10% of its then outstanding shares and provide inter-island travel benefits to certain former Aloha Airlines employees. The Company recorded a charge of $2.8 million related to this transaction in the fourth fiscal quarter of 2008. Under the terms of the settlement, if the shareholder is able to purchase the "Aloha" name in the bankruptcy court auction, it will license the "Aloha" name to Mesa.

* Maintenance: Maintenance expense decreased 31.7% as compared to the first quarter of fiscal 2008. This $22.8 million spending reduction is mainly attributed to savings in engine repair costs resulting from the termination of a power by the hour contract and a decrease in expense associated with component contracts due to contract amendments.

* Inventory: In the first quarter Mesa financed $2.9 million of certain rotable spare parts at an annual interest rate of 3.2% for 60 months. The first principal payment of $82,057 is due and payable on the 21st month. Interest will be accrued and added to the principal of the note for the first 20 months of the arrangement.

* Bonds: The Company purchased certain senior convertible notes during the first quarter. These notes, due in February 2024, were reacquired at a substantial discount and resulted in a recorded gain of approximately $8.1 million.

"We are encouraged by this quarter's performance and the strides we have taken to put some difficult hurdles behind us. We are also very pleased to report go! achieved its first quarterly profit and we remain committed to our independent inter-island operation," said Mesa Chairman and CEO, Jonathan Ornstein. "We continue to execute our restructuring plan and take steps needed to improve the financial and operational performance of the Company. We would like to thank all of our constituents who have worked with us including our airline partners, vendors and suppliers, bondholders and our hard working employees and employee leadership team. While the environment continues to be challenging we remain confident that working together our company can build upon the success of this quarter."

XINHUA CHINA LIMITED (OTCBB: XHUA)
"Up 125.00% in morning trading"

Detailed Quote: http://www.otcpicks.com/quotes/XHUA.php

Xinhua China, Ltd. operates as a co-publishing and digital media company. It engages in Internet book distribution business. The company is based in Beijing, the People's Republic of China.

XHUA News:

February 17 - Xinhua China Ltd. Files Quarterly Report

Visit http://yahoo.brand.edgar-online.com/default.aspx?cik=1104904 to view Xinhua China, Limited's (OTCBB: XHUA) most recent quarterly filing.

ORIGINOIL INCORPORATED (OTCBB: OOIL)
"Up 7.89% in morning trading"

Detailed Quote: http://www.otcpicks.com/quotes/OOIL.php

OriginOil, Inc., a development stage company, focuses on developing a technology to transform algae into an alternative to petroleum. Its patent-pending OriginOil System is an advanced bioreactor system, in which microalgae would grow and crack to extract algae oil for fuel and chemical production. The company was founded in June 2007 and is based in Los Angeles, California.

OOIL News:

February 17 - OriginOil Signs Cooperative Agreement with Department of Energy

OriginOil, Inc. (OTCBB: OOIL), the developer of a breakthrough technology to transform algae, the most promising source of renewable oil, into a true competitor to petroleum, announced that it has signed a Cooperative Agreement with The United States Department of Energy's Idaho National Laboratory (INL).

The multi-phase research program will focus on validation and commercial scaling of the company’s technology in the production of algae-based fuels by utilizing the state-of-the-art equipment, capabilities, scientists and engineers of the INL. The initial phase, which starts immediately, will focus on the collaborative development of an energy balance model for photobioreactor-based algae systems. OriginOil expects to use this model in the optimization of its algae-to-oil technology as early as the 1st Quarter of 2009. Subsequent phases will center on validation of the OriginOil processes and piloting specific commercial applications.

Thomas H. Ulrich, PhD, Advisory Scientist for INL’s Biofuels and Renewable Energy department, said: “INL has been tasked with the key National Security mandate of developing advanced renewable energy technology. Our primary challenge is cost-effective and scalable industrial processes and our partnership with OriginOil will help us find solutions to this challenge in the promising area of algae-to-oil technology. Partnerships with innovators like OriginOil will accelerate our pursuit of national energy independence initiatives.”

Vikram M. Pattarkine, PhD, OriginOil’s chief technology officer, said, “Because algae represents such promise, we have been presented with numerous opportunities for partnerships in the public and private sector in the US and abroad. We decided to begin with INL because it would be very productive across all of our initiatives.”

In operation since 1949, the Idaho National Laboratory (www.inl.gov) is a science-based, applied engineering national laboratory dedicated to supporting the Department of Energy (DOE) on energy research and national defense. Its mission is to ensure the nation's energy security with safe, competitive and sustainable energy systems and unique national and homeland security capabilities.

ABOUT IDAHO NATIONAL LABORATORY

With more than 300 scientists and engineers, INL's Energy, Environment Science & Technology Directorate integrates nuclear energy research and its unconventional application with other bio and fossil energy systems, advances renewable energy technologies and develops alternative energy sources and transportation fuels. With science and engineering capabilities in key areas, the Directorate provides talent to support research efforts in all energy systems and the support research and development needed for national and homeland security technologies.

Beacon Equity Updates OOIL Rating Based on Cooperative Clean Energy Agreement and Technology Advances

OriginOil Inc. (OTCBB: OOIL) has received a reiterated “Speculative Buy” rating by Beacon Analyst, Victor Sula, Ph.D.

The full report is available at www.beaconequity.com.

In the report, the analyst writes, “In February 2009, OOIL announced a cooperative agreement with the U.S. Department of Energy's Idaho National Laboratory (INL). The parties agreed upon a multi-phase research program that will focus on validating and commercially scaling OOIL’s technology for producing algae-based fuels, utilizing INL’s state-of-the-art equipment, capabilities, scientists and engineers. … Robust clean energy demand, OOIL’s progress in advancing its biofuel technology, and the significant revenue stream likely to result from royalties and licensing fees, are reasons we continue to rate OOIL a Speculative Buy.”

Other companies in the research services industry include: Nanoforce Inc. (OTC: NNFC), PetroSun Inc. (OTC: PSUD), Green Star Products Inc. (OTC: GSPI) and Valcent Products Inc. (OTCBB: VCTPF).

NEOHYDRO TECHNOLOGIES CORPORATION (OTCBB: NHYT)
"Up 11.11% in morning trading"

Detailed Quote: www.otcpicks.com/quotes/NHYT.php

Neohydro Technologies Corp. engages in the acquisition and exploration of mineral resources. It intends to explore for gold. It owns interest in the Rio Lode Claim, which is located within the Yellow Pine Mining District of Clark County, Nevada. The company, formerly known as Rioridge Resources Corp., was founded in 2007 and is based in Piscataway, New Jersey.

NHYT News:

February 19 - Neohydro Technologies Corporation Receives Endorsement from Houston ‘Think Tank’

Neohydro Technologies Corp. (OTCBB: NHYT) announced that after months of evaluations, due diligence, and an extensive interview process, the Houston Technology Center has approved Neohydro’s application as an energy client.

The Houston Technology Center (HTC) is a non-profit business accelerator and the largest technology business incubator in Texas, supported by more than 300 corporations and organizations that assists Houston-based emerging technology companies to commercialization.

Dean Themy, CEO of Neohydro states, “We are so honored and privileged to have our Company approved to be part of such a successful entity. Being in Houston, the hub of the Oil and Gas industry has been great for our Company and the marketability of our technology. Becoming an HTC member was not easy as it is not open to all, so our membership is a milestone and a validation of our Company’s value proposition. We have received a tremendous amount of support, encouragement, and guidance on our business model and with the team of experts at HTC we are even more certain that our proprietary high voltage electrolysis / electro coagulation wastewater renewal systems will reach its full potential in the commercial marketplace, specifically the treatment of waste water in the oil and gas industry.”

ABOUT THE HOUSTON TECHNOLOGY CENTER

Houston Technology Center (HTC), a non-profit 501(c)(3)organization, is a business accelerator and the largest technology business incubator in Texas, supported by more than 300 corporations and organizations, Houston's leading academic institutions, Greater Houston Partnership, Texas Medical Center, NASA-Johnson Space Center, and the City of Houston.

Accelerating the commercialization of emerging technology companies by providing in-depth business guidance, access to capital and service providers, and entrepreneurial education, HTC has become the center of technology entrepreneurship, assisting more than 200 companies within several key sectors: Energy, Technology, Life Sciences, Nanotechnology, and NASA/Aerospace technologies.

HTC serves as the Gulf Coast Regional Center for the Texas Emerging Technology Fund, helping small to mid-size companies expediting the commercialization of new technologies.

SOMATIC SYSTEMS INCORPORATED (OTC: SMAS)

Detailed Quote: http://www.otcpicks.com/quotes/SMAS.php

Somatic Systems is the worldwide center for Clinical Somatics™, the groundbreaking drug-free, non-surgical approach to pain relief. This proprietary system uses natural, non-invasive movement techniques — conducted through one-hour hands-on sessions, therapeutic exercises classes, and home exercises lasting as little as 5 minutes a day — to relieve pain and limitation resulting from accident, trauma and repetitive stress, including back pain, knee pain, joint problems, carpal tunnel syndrome, TMJ, scoliosis, bursitis, sciatica, headaches, tendonitis and more. Clinical Somatics™ also provides performance gains and injury prevention for casual and professional athletes. Somatic Systems is pursuing a 3-part growth strategy, consisting of a nationwide rollout of pain management Somatics Clinics; increased production and distribution of therapeutic videos, books, and other retail self-help Somatics Products; and expanded Somatics Training Programs to supply Clinic practitioners serving medical and orthopedic professionals and institutional and corporate programs. The company operates a suite of web sites offering Somatics information, products, resources and opportunities at www.somatics.org.

SMAS News:

February 19 - Somatic Systems, Inc. Featured at 2009 Equities on the Strip Conference

Somatic Systems, Inc. (OTC: SMAS), a leader in pain management providing its cutting edge Clinical Somatics therapies, presented at the 2009 Equities on the Strip Conference at Bally's Hotel and Casino in Las Vegas, Nevada.

The event, held February 15-17, included over 40 undiscovered public and private companies and was hosted by Nortia Capital Partners in partnership with Stocknewsnow.com and Undiscovered Equities. The conference provided Somatic Systems with a unique opportunity to present and network with investors, investment bankers and fund managers.

Somatic Systems' CEO Steven Aronstein presented the company's powerful system for treating chronic pain and injury. Aronstein also presented the company's current growth and activities, and plans and strategies for expansion. Additionally, Somatic Systems' efforts with the US Military to begin providing pain management services this month as well as to obtain coverage by Tricare military health insurance were discussed, including the competitive advantages of the market of 74 million soldiers, veterans, and dependents reached by this plan. Other topics included upcoming media coverage and product releases.

Information about the conference can be found at www.smallcapconferences.com or www.nortiacapital.com.

ABOUT NORTIA INVESTMENT EVENTS

Nortia Investment Events host elite events where members of the financial community, including a portfolio managers, analysts, fund managers, brokers, investment bankers, and individual investors, rub shoulders with select senior management of publicly-held and privately-held companies at formal presentations; over breakfast, lunch, special cocktail receptions and throughout the conference; and at special panel discussions and speeches.